Literature DB >> 15784554

Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody.

Gregory R Moe1, Apurva Dave, Dan M Granoff.   

Abstract

The capsular polysaccharide of Neisseria meningitidis group B (MBPS) is a polymer of alpha (2-->8) N-acetyl neuraminic acid. The polysaccharide is chemically identical to an autoantigen, polysialic acid (PSA), and is a poor immunogen, even when conjugated to protein carriers. Immunization of mice with MBPS-protein conjugate vaccines, in which N-acetyl groups have been replaced by propionyl groups (N-Pr MBPS), elicits serum bactericidal antibodies. A subpopulation of these antibodies do not cross-react with human PSA. The reasons for the increased immunogenicity of N-Pr MBPS and the antigenic targets of the bactericidal nonautoreactive antibodies are unknown. In this study, we investigated the antigenic targets of a protective murine monoclonal antibody (MAb) prepared against a N-Pr MBPS-tetanus toxoid conjugate vaccine. Binding of the MAb to N-Pr MBPS (as demonstrated by an enzyme-linked immunosorbent assay) and bactericidal activity were inhibited by de-N-acetylated MBPS and re-N-acetylated MBPS, which indicate that N-propionyl groups are not obligatory determinants for binding. The results of affinity selection from a preparation of N-Pr MBPS and matrix-assisted laser desorption ionization-time of flight mass spectroscopic analysis indicated that the minimal epitope recognized by the MAb is a MBPS disaccharide containing one de-N-acetylated residue. Thus, the bacterial capsular epitope recognized by this bactericidal, nonautoreactive, anti-group-B MAb likely contains de-N-acetyl residues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784554      PMCID: PMC1087408          DOI: 10.1128/IAI.73.4.2123-2128.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

2.  Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates.

Authors:  P C Fusco; F Michon; J Y Tai; M S Blake
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

3.  Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.

Authors:  D M Granoff; A Bartoloni; S Ricci; E Gallo; D Rosa; N Ravenscroft; V Guarnieri; R C Seid; A Shan; W R Usinger; S Tan; Y E McHugh; G R Moe
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

4.  Differences in surface expression of NspA among Neisseria meningitidis group B strains.

Authors:  G R Moe; S Tan; D M Granoff
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes.

Authors:  J S Shin; J S Lin; P W Anderson; R A Insel; M H Nahm
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines.

Authors:  P Costantino; F Norelli; A Giannozzi; S D'Ascenzi; A Bartoloni; S Kaur; D Tang; R Seid; S Viti; R Paffetti; M Bigio; C Pennatini; G Averani; V Guarnieri; E Gallo; N Ravenscroft; C Lazzeroni; R Rappuoli; C Ceccarini
Journal:  Vaccine       Date:  1999-03-05       Impact factor: 3.641

7.  Regulation of selectin binding activity by cyclization of sialic acid moiety of carbohydrate ligands on human leukocytes.

Authors:  C Mitsuoka; K Ohmori; N Kimura; A Kanamori; S Komba; H Ishida; M Kiso; R Kannagi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1.

Authors:  F H Azmi; A H Lucas; H V Raff; D M Granoff
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 A resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for alpha-(2-->8)-polysialic acid.

Authors:  S V Evans; B W Sigurskjold; H J Jennings; J R Brisson; R To; W C Tse; E Altman; M Frosch; C Weisgerber; H D Kratzin
Journal:  Biochemistry       Date:  1995-05-23       Impact factor: 3.162

10.  N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.

Authors:  R A Pon; M Lussier; Q L Yang; H J Jennings
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

View more
  10 in total

1.  Specificity of the immune response to a modified group B meningococcal polysaccharide conjugate vaccine.

Authors:  Samuel Moore; Esmé K Farley; Peter C Fusco; Francis Michon
Journal:  Clin Vaccine Immunol       Date:  2006-11-01

2.  Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: chemical strategies to prepare glycoconjugates with good carbohydrate loading.

Authors:  Andrew D Cox; Frank St Michael; Dhamodharan Neelamegan; Suzanne Lacelle; Chantelle Cairns; James C Richards
Journal:  Glycoconj J       Date:  2010-03-26       Impact factor: 2.916

3.  The expression profile of de-N-acetyl polysialic acid (NeuPSA) in normal and diseased human tissue.

Authors:  Taizo A Nakano; Lindsay M Steirer; Gregory R Moe
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

4.  Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies.

Authors:  Gregory R Moe; Apurva Dave; Dan M Granoff
Journal:  Mol Immunol       Date:  2005-09-02       Impact factor: 4.407

5.  Evidence for rosettes as an unrecognized stage in the life cycle of Leishmania parasites.

Authors:  David M Iovannisci; C Paul Plested; Gregory R Moe
Journal:  J Eukaryot Microbiol       Date:  2010-08-05       Impact factor: 3.346

6.  Effect of human serum on de-N-acetyl sialic acid epitope expression and antibody activity against N. meningitidis group B.

Authors:  Becca A Flitter; Jessica Y Ing; Gregory R Moe
Journal:  Vaccine       Date:  2010-07-15       Impact factor: 3.641

7.  Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines.

Authors:  Tyler D Moeller; Kevin B Weyant; Matthew P DeLisa
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

8.  Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against neisseria meningitidis groups B and C.

Authors:  Gregory R Moe; Tamara S Bhandari; Becca A Flitter
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  An antibody to de-N-acetyl sialic acid containing-polysialic acid identifies an intracellular antigen and induces apoptosis in human cancer cell lines.

Authors:  Lindsay M Steirer; Gregory R Moe
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

10.  A cancer-unique glycan: de-N-acetyl polysialic acid (dPSA) linked to cell surface nucleolin depends on re-expression of the fetal polysialyltransferase ST8SIA2 gene.

Authors:  Gregory R Moe; Lindsay M Steirer; Joshua A Lee; Adarsha Shivakumar; Alejandro D Bolanos
Journal:  J Exp Clin Cancer Res       Date:  2021-09-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.